A case report on the safety and efficacy of aripiprazole for depression in Brugada syndrome
Clozapine is the only medication approved for treatment-resistant schizophrenia. Clozapine toxicity associated with COVID-19 infection could be amplified by concomitant nirmatrelvir/ritonavir. Knowledge gaps among clinicians and patients led to patient safety concerns and the implementation of a qua...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Association of Psychiatric Pharmacists
2025-04-01
|
| Edice: | Mental Health Clinician |
| Témata: | |
| On-line přístup: | https://theijpt.org/doi/pdf/10.9740/mhc.2025.04.062 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|